Mechanisms and strategies to overcome resistance to enfortumab vedotin in bladder cancer.

被引：0
|
作者：
Chang, Kevin [1 ]
Lodha, Roshan [2 ]
Delavan, Henry M. [3 ]
Winebaum, Jenna [3 ]
Porten, Sima P. [1 ]
Feng, Felix Y. [3 ]
Chu, Carissa E. [1 ]
Chou, Jonathan
机构：
[1] Univ Calif San Francisco, San Francisco, CA USA
[2] Cleveland Clin, Lerner Coll Med, Cleveland Hts, OH USA
[3] Univ Calif San Francisco, Helen Diller Family Comprehens Canc Ctr, San Francisco, CA USA
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2024年 / 42卷 / 4_SUPPL期
关键词：
3282-646-2719; 613-615-646-4685-2424; 283-183-138-226-9326; 283-183-138-11076; 261-374-2500-10670-7136; 5; 3; 2; 3224; 1876; 1; 38092-33344; 38092-27054;
D O I：
10.1200/JCO.2024.42.4_suppl.690
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：690 / 690
页数：1
相关论文
共 50 条
  • [21] EV-103: Enfortumab vedotin plus pembrolizumab and/or chemotherapy for locally advanced or metastatic urothelial cancer.
    Hoimes, Christopher J.
    Rosenberg, Jonathan E.
    Petrylak, Daniel Peter
    Carret, Anne-Sophie
    Melhem-Bertrandt, Amal
    Flaig, Thomas W.
    JOURNAL OF CLINICAL ONCOLOGY, 2019, 37 (15)
  • [22] Deciphering resistance mechanisms and novel strategies to overcome drug resistance in ovarian cancer: a comprehensive review
    Alemzadeh, Ffat
    Allahqoli, Leila
    Mazidimoradi, Afrooz
    Alemzadeh, Esmat
    Ghasemi, Fahimeh
    Salehiniya, Hamid
    Alkatout, Ibrahim
    ONCOLOGY RESEARCH, 2024, 32 (05) : 831 - 847
  • [23] Enfortumab vedotin 202: Phase 2 study of enfortumab vedotin for previously treated advanced solid tumors, including breast cancer
    Ono, Makiko
    Bruce, Justine Yang
    Feinstein, Trevor
    Muro, Kei
    Derleth, Christina
    Gorla, Seema
    Wu, Chunzhang
    Novik, Yelena
    CANCER RESEARCH, 2022, 82 (04)
  • [24] Mechanisms and strategies to overcome immunotherapy resistance in hepatobiliary malignancies
    Xiong, Jia
    Wang, Qing-Qing
    HEPATOBILIARY & PANCREATIC DISEASES INTERNATIONAL, 2022, 21 (05) : 430 - 439
  • [25] Mechanisms of and Strategies to overcome multidrug resistance of genitourinary tumors
    van Brussel, JP
    van Steenbrugge, GJ
    Mickisch, GHJ
    AKTUELLE UROLOGIE, 1998, 29 (05) : 206 - 220
  • [26] MOLECULAR MECHANISMS OF RITUXIMAB RESISTANCE AND STRATEGIES TO OVERCOME THEM
    Tomita, A.
    ANNALS OF ONCOLOGY, 2012, 23 : 78 - 78
  • [27] Probing antimicrobial mechanisms for effective strategies to overcome resistance
    Ravi, J.
    Pfeil, M. P.
    Pyne, A. L.
    EUROPEAN BIOPHYSICS JOURNAL WITH BIOPHYSICS LETTERS, 2019, 48 : S223 - S223
  • [28] Mechanisms and strategies to overcome immunotherapy resistance in hepatobiliary malignancies
    Jia Xiong
    Qing-Qing Wang
    Hepatobiliary&PancreaticDiseasesInternational, 2022, 21 (05) : 430 - 439
  • [29] Escaping ALK Inhibition: Mechanisms of and Strategies to Overcome Resistance
    Lovly, Christine M.
    Pao, William
    SCIENCE TRANSLATIONAL MEDICINE, 2012, 4 (120)
  • [30] Re: Enfortumab Vedotin and Pembrolizumab in Untreated Advanced Urothelial Cancer
    Catalano, Martina
    Santoni, Matteo
    Roviello, Giandomenico
    EUROPEAN UROLOGY, 2024, 86 (03) : 283 - 283
12345